Data as of Dec 19
| +0.54 / +3.14%|
The 10 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 24.00 and a low estimate of 15.00. The median estimate represents a +7.16% increase from the last price of 17.73.
The current consensus among 12 polled investment analysts is to Buy stock in Infinity Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.